Efforts for Expedited Process to Get Medical Marijuana Lauded in Nevada
- LEGALITIES, MEDICAL MARIJUANA, NEWS
- June 22, 2016
In 2021, Alabama took a significant step by approving a medical marijuana program, promising relief for patients with qualifying conditions. However, three years later, patients are still waiting for access to cannabis products. The delays have been attributed to bureaucratic hurdles and regulatory challenges that have slowed the program’s implementation. Despite the initial optimism, the
READ MOREIn a significant development for medical marijuana advocates in Arkansas, state officials have granted an additional 30 days for the collection of signatures to support a ballot initiative aimed at expanding the state’s medical cannabis program. The campaign, led by Arkansans for Patient Access (APA), initially submitted nearly 110,000 signatures but fell short of the
READ MOREAs marijuana use becomes increasingly mainstream, researchers are finally able to study its effects more thoroughly. A recent article in Scientific American explores the latest findings on cannabis and health, revealing a complex picture. While marijuana offers potential benefits for pain relief, nausea reduction, and epilepsy treatment, it also carries risks. Heavy use has been
READ MOREIn a significant move towards cannabis reform, Senator Gary Peters (D-MI) has introduced the Dismantling Outdated Obstacles and Barriers to Individual Employment (DOOBIE) Act in the U.S. Senate. The proposed legislation aims to protect individuals from being denied federal employment or security clearances due to past marijuana use. This initiative reflects a growing recognition of
READ MOREKansas legislators are gearing up to tackle the complex issue of medical marijuana in preparation for the 2025 legislative session. The Legislative Coordinating Council has approved two days of interim hearings, as reported by the Kansas Reflector, to explore the potential for legalizing medical cannabis in the state. Senator Michael Fagg, who championed the hearings, emphasized
READ MOREIn a groundbreaking move, the Drug Enforcement Administration (DEA) is proposing regulations that would reclassify cannabis as medicine rather than an illicit drug. This potential shift to Schedule III classification could have far-reaching implications for both patients and researchers. While cannabis would still be available at state-authorized dispensaries, the reclassification could pave the way for
READ MORE